NABP Exam NAPLEX Topic 7 Question 15 Discussion

Actual exam question for NABP's NAPLEX exam

Question #: 15
Topic #: 7

In a study where Rivaroxaban was compared to Enoxaparin to find total VTE following HIP replacement surgery, there were 17 total VTE out of 1513 patients in the Rivaraoaban group and 57 total VTE out of 1473 patient in the enoxaparin group.

What is the absolute risk reduction of using Rivaroxaban over Enoxaparin?

A17

B57

C71

D2.7

E0.27

Show Suggested Answer

Suggested Answer: D

Absolute risk reduction: 0.027 = 2.7% (Event rate in enoxaparin group) -- (Event rate in rivaroxaban group) = (57/1473) -- (17/1513) = 0.02746

by Kaitlyn at May 06, 2022, 11:20 AM

Limited Time Offer

25%

Off

Get Premium NAPLEX Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

Submit Cancel

Currently there are no comments in this discussion, be the first to comment!